全文获取类型
收费全文 | 67910篇 |
免费 | 5806篇 |
国内免费 | 1326篇 |
专业分类
耳鼻咽喉 | 302篇 |
儿科学 | 1120篇 |
妇产科学 | 948篇 |
基础医学 | 6268篇 |
口腔科学 | 385篇 |
临床医学 | 6641篇 |
内科学 | 8745篇 |
皮肤病学 | 528篇 |
神经病学 | 1595篇 |
特种医学 | 3288篇 |
外国民族医学 | 24篇 |
外科学 | 6204篇 |
综合类 | 9476篇 |
现状与发展 | 3篇 |
一般理论 | 2篇 |
预防医学 | 4286篇 |
眼科学 | 775篇 |
药学 | 5570篇 |
36篇 | |
中国医学 | 2272篇 |
肿瘤学 | 16574篇 |
出版年
2024年 | 107篇 |
2023年 | 1055篇 |
2022年 | 2133篇 |
2021年 | 2959篇 |
2020年 | 2420篇 |
2019年 | 2793篇 |
2018年 | 2806篇 |
2017年 | 2653篇 |
2016年 | 2397篇 |
2015年 | 2495篇 |
2014年 | 5918篇 |
2013年 | 5286篇 |
2012年 | 4243篇 |
2011年 | 4577篇 |
2010年 | 3828篇 |
2009年 | 3692篇 |
2008年 | 3600篇 |
2007年 | 3060篇 |
2006年 | 2525篇 |
2005年 | 2084篇 |
2004年 | 1837篇 |
2003年 | 1619篇 |
2002年 | 1236篇 |
2001年 | 1218篇 |
2000年 | 1079篇 |
1999年 | 900篇 |
1998年 | 732篇 |
1997年 | 664篇 |
1996年 | 584篇 |
1995年 | 545篇 |
1994年 | 504篇 |
1993年 | 357篇 |
1992年 | 318篇 |
1991年 | 250篇 |
1990年 | 221篇 |
1989年 | 227篇 |
1988年 | 179篇 |
1987年 | 148篇 |
1986年 | 118篇 |
1985年 | 219篇 |
1984年 | 231篇 |
1983年 | 164篇 |
1982年 | 203篇 |
1981年 | 162篇 |
1980年 | 164篇 |
1979年 | 119篇 |
1978年 | 96篇 |
1977年 | 67篇 |
1976年 | 63篇 |
1974年 | 53篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
23.
《The American journal of emergency medicine》2020,38(8):1695.e1-1695.e3
Catamenial hemothorax is a rare manifestation of thoracic endometriosis syndrome. It is commonly seen associated with pelvic endometriosis in nulliparous reproductive-age women. Most cases are minor and self-limiting. We present a case of a 32-year-old woman who presented with prolonged worsening dyspnea and was found to have a massive hemothorax on evaluation. 相似文献
24.
Whitney S. Brandt Wanpu Yan Jian Zhou Kay See Tan Joseph Montecalvo Bernard J. Park Prasad S. Adusumilli James Huang Matthew J. Bott Valerie W. Rusch Daniela Molena William D. Travis Mark G. Kris Jamie E. Chaft David R. Jones 《The Journal of thoracic and cardiovascular surgery》2019,157(2):743-753.e3
Objective
Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.Methods
Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.Results
In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.Conclusions
Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection. 相似文献25.
26.
目的:探讨3D-CRT 低剂量区 V5体积的大小对非小细胞肺癌患者肺功能的影响。方法:收集我院肿瘤科2014年4月~2015年10月收治的46例首次行三维适形放射治疗且顺利完成治疗的非小细胞肺癌患者,对每例患者分别在治疗前以及治疗后的1、3个月进行肺功能检测,分析3D-CRT 低剂量区 V5体积的大小与肺功能变化之间的关系。结果:放疗后1个月的 FEV1%、FVC%值明显高于放疗前且差异均具有显著性。放疗后1个月、3个月的 DLCO%值明显低于放疗前,且放疗前的与放疗后3个月的差异具有显著性;V5≦45%、45%55%三组放疗前后的 FEV1%值和 FVC%值比较差异均不具有显著性。V5≦45%、45%55%三组放疗前后的 DLCO%值均呈逐渐下降趋势,且 V5>55%组的放疗前后 DLCO%值比较差异具有显著性。而 V5≦45%组和45%55%时,DLCO%值降低的趋势更加显著。 相似文献
27.
《Pediatric clinics of North America》2015,62(6):1463-1477
28.
29.
《Biomaterials》2015
The human mutT homologue MTH1, a nucleotide pool sanitizing enzyme, represents a vulnerability factor and an attractive target for anticancer therapy. However, there is currently a lack of selective and effective platforms for the detection and inhibition of MTH1 in cells. Here, we demonstrate for the first time a gold nanoparticle (AuNP) flares-capped mesoporous silica nanoparticle (MSN) nanoplatform that is capable of detecting MTH1 mRNA and simultaneously suppressing MTH1 activity. The AuNP flares are made from AuNPs that are functionalized with a dense shell of MTH1 recognition sequences hybridized to short cyanine (Cy5)-labeled reporter sequences and employed to seal the pores of MSN to prevent the premature MTH1 inhibitors (S-crizotinib) release. Just like the pyrotechnic flares that produce brilliant light when activated, the resulting AuNP flares@MSN (S-crizotinib) undergo a significant burst of red fluorescence enhancement upon MTH1 mRNA binding. This hybridization event subsequently induces the opening of the pores and the release of S-crizotinib in an mRNA-dependent manner, leading to significant cytotoxicity in cancer cells and improved therapeutic response in mouse xenograft models. We anticipate that this nanoplatform may be an important step toward the development of MTH1-targeting theranostics and also be a useful tool for cancer phenotypic lethal anticancer therapy. 相似文献
30.
《Annales médico-psychologiques》2022,180(8):773-779
Adolescent and young adult cancer – AYA – enters a period of life during which a dynamic developmental process takes place, particularly with the existential issues of separation-individualization and empowerment at stake. The experience of cancer is in fact a major ordeal, a major upheaval not only for the young person but also for his entire family. This review of the narrative literature aims to take stock of current knowledge on the psychological repercussions of serious illness on the AYA and his family. After presenting results, we will propose recommendations for the clinic and avenues for future research. 相似文献